Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Sahlgrenska University Hospital
Gotemburgo, SueciaPublicaciones en colaboración con investigadores/as de Sahlgrenska University Hospital (6)
2021
-
LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression
Oncogene, Vol. 40, Núm. 13, pp. 2463-2478
-
Subcellular distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma
Cancer Research, Vol. 81, Núm. 6, pp. 1457-1471
2020
-
The importance of naturally attenuated SARS-CoV-2in the fight against COVID-19
Environmental Microbiology, Vol. 22, Núm. 6, pp. 1997-2000
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2004
-
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: Results of a randomized trial
Circulation, Vol. 110, Núm. 5, pp. 552-557
-
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells
Human Molecular Genetics, Vol. 13, Núm. 22, pp. 2753-2765